Results
|
861.
|
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma. [electronic resource] by
- Burke, John M
- Shustov, Andrei
- Essell, James
- Patel-Donnelly, Dipti
- Yang, Jay
- Chen, Robert
- Ye, Wei
- Shi, Wen
- Assouline, Sarit
- Sharman, Jeff
Producer: 20191022
In:
Clinical lymphoma, myeloma & leukemia vol. 18
Availability: No items available.
|
|
862.
|
Microglial TREM-1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke. [electronic resource] by
- Xu, Pengfei
- Zhang, Xiaohao
- Liu, Qian
- Xie, Yi
- Shi, Xiaolei
- Chen, Jingjing
- Li, Yunzi
- Guo, Hongquan
- Sun, Rui
- Hong, Ye
- Liu, Xinfeng
- Xu, Gelin
Producer: 20200803
In:
Cell death & disease vol. 10
Availability: No items available.
|
|
863.
|
|
|
864.
|
|
|
865.
|
|
|
866.
|
|
|
867.
|
|
|
868.
|
Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness. [electronic resource] by
- Matsubara, Shigeki
- Li, Guiming
- Takeda, Katsuyuki
- Loader, Joan E
- Pine, Polly
- Masuda, Esteban S
- Miyahara, Nobuaki
- Miyahara, Satoko
- Lucas, Joseph J
- Dakhama, Azzeddine
- Gelfand, Erwin W
Producer: 20060321
In:
American journal of respiratory and critical care medicine vol. 173
Availability: No items available.
|
|
869.
|
|
|
870.
|
|
|
871.
|
|
|
872.
|
|
|
873.
|
The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study. [electronic resource] by
- Golouh, Rastko
- Cufer, Tanja
- Sadikov, Aleksander
- Nussdorfer, Petra
- Usher, Pernille Autzen
- Brünner, Nils
- Schmitt, Manfred
- Lesche, Ralf
- Maier, Sabine
- Timmermans, Mieke
- Foekens, John A
- Martens, John W M
Producer: 20090424
In:
Breast cancer research and treatment vol. 110
Availability: No items available.
|
|
874.
|
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors. [electronic resource] by
- Padilla, Fernando
- Bhagirath, Niala
- Chen, Shaoqing
- Chiao, Eric
- Goldstein, David M
- Hermann, Johannes C
- Hsu, Jonathan
- Kennedy-Smith, Joshua J
- Kuglstatter, Andreas
- Liao, Cheng
- Liu, Wenjian
- Lowrie, Lee E
- Luk, Kin Chun
- Lynch, Stephen M
- Menke, John
- Niu, Linghao
- Owens, Timothy D
- O-Yang, Counde
- Railkar, Aruna
- Schoenfeld, Ryan C
- Slade, Michelle
- Steiner, Sandra
- Tan, Yun-Chou
- Villaseñor, Armando G
- Wang, Ce
- Wanner, Jutta
- Xie, Wenwei
- Xu, Daigen
- Zhang, Xiaohu
- Zhou, Mingyan
- Lucas, Matthew C
Producer: 20130731
In:
Journal of medicinal chemistry vol. 56
Availability: No items available.
|
|
875.
|
|
|
876.
|
|
|
877.
|
|
|
878.
|
|
|
879.
|
|
|
880.
|
Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression. [electronic resource] by
- Lindau, Alexandra
- Härdtner, Carmen
- Hergeth, Sonja P
- Blanz, Kelly Daryll
- Dufner, Bianca
- Hoppe, Natalie
- Anto-Michel, Nathaly
- Kornemann, Jan
- Zou, Jiadai
- Gerhardt, Louisa M S
- Heidt, Timo
- Willecke, Florian
- Geis, Serjosha
- Stachon, Peter
- Wolf, Dennis
- Libby, Peter
- Swirski, Filip K
- Robbins, Clinton S
- McPheat, William
- Hawley, Shaun
- Braddock, Martin
- Gilsbach, Ralf
- Hein, Lutz
- von zur Mühlen, Constantin
- Bode, Christoph
- Zirlik, Andreas
- Hilgendorf, Ingo
Producer: 20161021
In:
Basic research in cardiology vol. 111
Availability: No items available.
|